Identification of a splicing variant that regulates type 2 diabetes risk factor CDKAL1 level by a coding-independent mechanism in human

Bo Zhou, Fan Yan Wei, Narumi Kanai, Atsushi Fujimura, Taku Kaitsuka, zuhito Tomizawa

研究成果: Article査読

36 被引用数 (Scopus)

抄録

Single-nucleotide polymorphisms (SNPs) in CDKAL1 have been associated with the development of type 2 diabetes (T2D). CDKAL1 catalyzes 2-methylthio modification of adenosine at position 37 of tRNALys(UUU). Adeficit of this modification causes aberrant protein synthesis, and is associated with impairment of insulin secretion in both mouse model and human. However, it is unknown whether the T2D-associated SNPs in CDKAL1 are associated with downregulation of CDKAL1 by regulating the gene expression. Here, we report a specific splicing variant of CDKAL1 termed CDKAL1-v1 that is markedly lower in individuals carrying risk SNPs of CDKAL1. Interestingly, CDKAL1-v1 is a non-coding transcript, which regulates the CDKAL1 level by competitive binding to a CDKAL1-targeting miRNA. By direct editing of the genome, we further show that the nucleotides around the SNPregions are critical for the alternative splicing of CDKAL1-v1. These findings reveal that the T2D-associated SNPs inCDKAL1 reduce CDKAL1-v1 levels by impairing splicing, which in turn increasesmiRNA-mediated suppression ofCDKAL1. Our results suggest that CDKAL1-v1-mediated suppression ofCDKAL1 might underlie the pathogenesis of T2D in individuals carrying the risk SNPs.

本文言語English
論文番号ddu184
ページ(範囲)4639-4650
ページ数12
ジャーナルHuman molecular genetics
23
17
DOI
出版ステータスPublished - 2014 9月
外部発表はい

ASJC Scopus subject areas

  • 分子生物学
  • 遺伝学
  • 遺伝学(臨床)

フィンガープリント

「Identification of a splicing variant that regulates type 2 diabetes risk factor CDKAL1 level by a coding-independent mechanism in human」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル